Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v4-EN
Language French English
Date Updated 2017-07-13 2017-06-16
Drug Identification Number 02370034 02370034
Brand name GEMCITABINE FOR INJECTION GEMCITABINE FOR INJECTION
Common or Proper name GEMCITABINE GEMCITABINE
Company Name ACCORD HEALTHCARE INC ACCORD HEALTHCARE INC
Ingredients GEMCITABINE GEMCITABINE
Strength(s) 2G 2G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2 G (POWDER) PER VIAL | FLACON DE 2 G (POUDRE) 2 G (POWDER) PER VIAL | FLACON DE 2 G (POUDRE)
ATC code L01BC L01BC
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-05-09 2017-05-09
Actual start date 2017-05-09 2017-05-09
Estimated end date 2017-07-07 2017-07-07
Actual end date 2017-07-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments